{"id":5697,"date":"2020-11-10T09:02:39","date_gmt":"2020-11-10T08:02:39","guid":{"rendered":"https:\/\/p664637.webspaceconfig.de\/?post_type=mediathek&#038;p=5697"},"modified":"2026-07-15T09:28:05","modified_gmt":"2026-07-15T07:28:05","slug":"catalym-raises-eur50-million-to-advance-gdf-15-antibody-into-clinical-trials-for-checkpoint-inhibitor-refractory-patients","status":"publish","type":"mediathek","link":"https:\/\/p664637.webspaceconfig.de\/en\/media-library\/press\/press-releases\/catalym-raises-eur50-million-to-advance-gdf-15-antibody-into-clinical-trials-for-checkpoint-inhibitor-refractory-patients\/","title":{"rendered":"CatalYm raises EUR50 million to advance GDF-15 antibody into clinical trials for checkpoint-inhibitor refractory patients"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":5695,"parent":0,"menu_order":0,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[201,202],"tags":[],"class_list":["post-5697","mediathek","type-mediathek","status-publish","format-standard","has-post-thumbnail","hentry","category-presse-en","category-pressemeldung-en"],"acf":[],"acf_migration":[],"wpml_migration":{"language_code":"en","source_language_code":"de","trid":"29463"},"yoast_migration":{"_yoast_wpseo_title":"CatalYm raises EUR50 million to advance GDF-15 antibody into clinical trials for checkpoint-inhibitor refractory patients - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB"},"permalink_migration":{"custom_uri":"media-library\/press\/press-releases\/catalym-raises-eur50-million-to-advance-gdf-15-antibody-into-clinical-trials-for-checkpoint-inhibitor-refractory-patients"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CatalYm raises EUR50 million to advance GDF-15 antibody into clinical trials for checkpoint-inhibitor refractory patients - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/p664637.webspaceconfig.de\/en\/media-library\/press\/press-releases\/catalym-raises-eur50-million-to-advance-gdf-15-antibody-into-clinical-trials-for-checkpoint-inhibitor-refractory-patients\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CatalYm raises EUR50 million to advance GDF-15 antibody into clinical trials for checkpoint-inhibitor refractory patients - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\" \/>\n<meta property=\"og:url\" content=\"https:\/\/p664637.webspaceconfig.de\/en\/media-library\/press\/press-releases\/catalym-raises-eur50-million-to-advance-gdf-15-antibody-into-clinical-trials-for-checkpoint-inhibitor-refractory-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-15T07:28:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/p664637.webspaceconfig.de\/wp-content\/uploads\/2026\/07\/CatalYm_Start-Up-im-IZB-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"273\" \/>\n\t<meta property=\"og:image:height\" content=\"198\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/media-library\\\/press\\\/press-releases\\\/catalym-raises-eur50-million-to-advance-gdf-15-antibody-into-clinical-trials-for-checkpoint-inhibitor-refractory-patients\\\/\",\"url\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/media-library\\\/press\\\/press-releases\\\/catalym-raises-eur50-million-to-advance-gdf-15-antibody-into-clinical-trials-for-checkpoint-inhibitor-refractory-patients\\\/\",\"name\":\"CatalYm raises EUR50 million to advance GDF-15 antibody into clinical trials for checkpoint-inhibitor refractory patients - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/media-library\\\/press\\\/press-releases\\\/catalym-raises-eur50-million-to-advance-gdf-15-antibody-into-clinical-trials-for-checkpoint-inhibitor-refractory-patients\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/media-library\\\/press\\\/press-releases\\\/catalym-raises-eur50-million-to-advance-gdf-15-antibody-into-clinical-trials-for-checkpoint-inhibitor-refractory-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/CatalYm_Start-Up-im-IZB-1.jpg\",\"datePublished\":\"2020-11-10T08:02:39+00:00\",\"dateModified\":\"2026-07-15T07:28:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/media-library\\\/press\\\/press-releases\\\/catalym-raises-eur50-million-to-advance-gdf-15-antibody-into-clinical-trials-for-checkpoint-inhibitor-refractory-patients\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/media-library\\\/press\\\/press-releases\\\/catalym-raises-eur50-million-to-advance-gdf-15-antibody-into-clinical-trials-for-checkpoint-inhibitor-refractory-patients\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/media-library\\\/press\\\/press-releases\\\/catalym-raises-eur50-million-to-advance-gdf-15-antibody-into-clinical-trials-for-checkpoint-inhibitor-refractory-patients\\\/#primaryimage\",\"url\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/CatalYm_Start-Up-im-IZB-1.jpg\",\"contentUrl\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/CatalYm_Start-Up-im-IZB-1.jpg\",\"width\":273,\"height\":198},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/media-library\\\/press\\\/press-releases\\\/catalym-raises-eur50-million-to-advance-gdf-15-antibody-into-clinical-trials-for-checkpoint-inhibitor-refractory-patients\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CatalYm raises EUR50 million to advance GDF-15 antibody into clinical trials for checkpoint-inhibitor refractory patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/\",\"name\":\"IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.\",\"description\":\"Der Ort f\u00fcr Biotech-Start-ups in M\u00fcnchen: Labore, B\u00fcror\u00e4ume, Netzwerk!\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CatalYm raises EUR50 million to advance GDF-15 antibody into clinical trials for checkpoint-inhibitor refractory patients - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/p664637.webspaceconfig.de\/en\/media-library\/press\/press-releases\/catalym-raises-eur50-million-to-advance-gdf-15-antibody-into-clinical-trials-for-checkpoint-inhibitor-refractory-patients\/","og_locale":"en_US","og_type":"article","og_title":"CatalYm raises EUR50 million to advance GDF-15 antibody into clinical trials for checkpoint-inhibitor refractory patients - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","og_url":"https:\/\/p664637.webspaceconfig.de\/en\/media-library\/press\/press-releases\/catalym-raises-eur50-million-to-advance-gdf-15-antibody-into-clinical-trials-for-checkpoint-inhibitor-refractory-patients\/","og_site_name":"IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.","article_modified_time":"2026-07-15T07:28:05+00:00","og_image":[{"width":273,"height":198,"url":"https:\/\/p664637.webspaceconfig.de\/wp-content\/uploads\/2026\/07\/CatalYm_Start-Up-im-IZB-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/p664637.webspaceconfig.de\/en\/media-library\/press\/press-releases\/catalym-raises-eur50-million-to-advance-gdf-15-antibody-into-clinical-trials-for-checkpoint-inhibitor-refractory-patients\/","url":"https:\/\/p664637.webspaceconfig.de\/en\/media-library\/press\/press-releases\/catalym-raises-eur50-million-to-advance-gdf-15-antibody-into-clinical-trials-for-checkpoint-inhibitor-refractory-patients\/","name":"CatalYm raises EUR50 million to advance GDF-15 antibody into clinical trials for checkpoint-inhibitor refractory patients - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","isPartOf":{"@id":"https:\/\/p664637.webspaceconfig.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/p664637.webspaceconfig.de\/en\/media-library\/press\/press-releases\/catalym-raises-eur50-million-to-advance-gdf-15-antibody-into-clinical-trials-for-checkpoint-inhibitor-refractory-patients\/#primaryimage"},"image":{"@id":"https:\/\/p664637.webspaceconfig.de\/en\/media-library\/press\/press-releases\/catalym-raises-eur50-million-to-advance-gdf-15-antibody-into-clinical-trials-for-checkpoint-inhibitor-refractory-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/p664637.webspaceconfig.de\/wp-content\/uploads\/2026\/07\/CatalYm_Start-Up-im-IZB-1.jpg","datePublished":"2020-11-10T08:02:39+00:00","dateModified":"2026-07-15T07:28:05+00:00","breadcrumb":{"@id":"https:\/\/p664637.webspaceconfig.de\/en\/media-library\/press\/press-releases\/catalym-raises-eur50-million-to-advance-gdf-15-antibody-into-clinical-trials-for-checkpoint-inhibitor-refractory-patients\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/p664637.webspaceconfig.de\/en\/media-library\/press\/press-releases\/catalym-raises-eur50-million-to-advance-gdf-15-antibody-into-clinical-trials-for-checkpoint-inhibitor-refractory-patients\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/p664637.webspaceconfig.de\/en\/media-library\/press\/press-releases\/catalym-raises-eur50-million-to-advance-gdf-15-antibody-into-clinical-trials-for-checkpoint-inhibitor-refractory-patients\/#primaryimage","url":"https:\/\/p664637.webspaceconfig.de\/wp-content\/uploads\/2026\/07\/CatalYm_Start-Up-im-IZB-1.jpg","contentUrl":"https:\/\/p664637.webspaceconfig.de\/wp-content\/uploads\/2026\/07\/CatalYm_Start-Up-im-IZB-1.jpg","width":273,"height":198},{"@type":"BreadcrumbList","@id":"https:\/\/p664637.webspaceconfig.de\/en\/media-library\/press\/press-releases\/catalym-raises-eur50-million-to-advance-gdf-15-antibody-into-clinical-trials-for-checkpoint-inhibitor-refractory-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/p664637.webspaceconfig.de\/en\/"},{"@type":"ListItem","position":2,"name":"CatalYm raises EUR50 million to advance GDF-15 antibody into clinical trials for checkpoint-inhibitor refractory patients"}]},{"@type":"WebSite","@id":"https:\/\/p664637.webspaceconfig.de\/en\/#website","url":"https:\/\/p664637.webspaceconfig.de\/en\/","name":"IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.","description":"Der Ort f\u00fcr Biotech-Start-ups in M\u00fcnchen: Labore, B\u00fcror\u00e4ume, Netzwerk!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/p664637.webspaceconfig.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/mediathek\/5697","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/mediathek"}],"about":[{"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/types\/mediathek"}],"version-history":[{"count":1,"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/mediathek\/5697\/revisions"}],"predecessor-version":[{"id":5701,"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/mediathek\/5697\/revisions\/5701"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/media\/5695"}],"wp:attachment":[{"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/media?parent=5697"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/categories?post=5697"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/tags?post=5697"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}